Joel Batten
About Joel Batten
Joel Batten serves as the Executive Vice President, GM, and Head of the Infectious Disease Franchise at Veru Inc., a position he has held since 2022. He previously held leadership roles at Sobi - North America and AstraZeneca, where he focused on government affairs and commercial strategy in the pharmaceutical industry.
Current Role at Veru
Joel Batten serves as the Executive Vice President, General Manager, and Head of the Infectious Disease Franchise at Veru Inc. since 2022. He is based in Miami, Florida. In this role, he oversees the strategic direction and operational management of the infectious disease division, focusing on advancing the company's initiatives in this critical area of healthcare.
Previous Experience at Sobi
Prior to joining Veru, Joel Batten worked at Sobi - North America as the Vice President and Infectious Disease Franchise Head from 2019 to 2022. During his tenure in Boston, Massachusetts, he was responsible for leading the infectious disease portfolio and driving business growth within the organization.
Career at AstraZeneca
Joel Batten held the position of Commercial Business Director at AstraZeneca from 2014 to 2019 in the Western United States. He led a team focused on government affairs, advocating for AstraZeneca's interests at the state level. His responsibilities included managing relationships with legislators and influencing Medicaid legislative language to ensure access to AstraZeneca's products.
Background in Government Affairs
Before his role at AstraZeneca, Joel Batten worked at MedImmune as the Government Affairs Manager from 2006 to 2014. He managed government relations in the Southeast United States and was involved with state chapters of BIO and PhRMA. His efforts included spearheading R&D tax-credit legislation in Maryland and Massachusetts, which resulted in significant tax credits for AstraZeneca.
Education and Qualifications
Joel Batten earned a Bachelor of Arts degree in Communications/Public Relations from the University of North Florida. His educational background has supported his career in the pharmaceutical industry, particularly in roles that require strong communication and relationship-building skills.